Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT04081688 2026-02-05

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Phase 1 Terminated

16 enrolled 9 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04778839 2025-08-06

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Phase 1 Recruiting

98 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms

NCT06299371 2024-03-07

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Phase 2 Not yet recruiting

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04840290 2021-04-21

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase 3 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04167774 2019-11-22

Compass-001

Phase 2 Unknown

62 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02603003 2019-09-20

CTC-TCM-FZ

Phase 1 Completed

218 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Clinical Trials

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Luscid

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Compass-001

CTC-TCM-FZ